Naples, Florida - February 09, 2026 - PRESSADVANTAGE - WhiteSands Treatment has released a new educational resource ...

A preclinical study by scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity—two issues ...

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other ...

Regular family meals may help discourage substance use in teenagers through consistent communication and strong parental ...

People are using GLP-1s to cut back on alcohol use disorder, but there are already three FDA-approved drugs: naltrexone, acamprosate, and disulfiram.

Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged. Beyond helping people shed pounds, they also lower the risk of heart ...

Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, according to new research. The study found participants on these medications felt ...

MIAMI — When Susan Akin first started injecting a coveted weight-loss drug early this year, the chaos in her brain quieted. The relentless cravings subsided — only they’d never been for food. The ...

Could taking popular GLP-1 weight loss drugs help curb alcohol use? Well, researchers say they already are. Taking semaglutide and liraglutide — a lesser-known active ingredient — medications for ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...